Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy

Barchart · 2d ago

Patent expands protection for technology designed to sense, map and selectively target nerves associated with tumors and cancer-related pain

Strengthens Autonomix’s platform opportunity across oncology, autonomic nervous system disorders and broader organ-function applications

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.